![Philip A. Sobol](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Philip A. Sobol
Directeur/Membre du Conseil chez S&B Surgery Center
Profil
Dr. Philip A.
Sobol, MD, is a Managing Director at Sobol Orthopedic Medical Group.
He is on the Board of Directors at Entia Biosciences, Inc. and S&B Surgery Center.
Dr. Sobol was previously employed as an Assistant Clinical Professor by University of Southern California.
He also served on the board at Cordex Pharma, Inc.
He received his undergraduate degree from the University of Rochester and a doctorate degree from the University of Southern California.
Postes actifs de Philip A. Sobol
Sociétés | Poste | Début |
---|---|---|
Sobol Orthopedic Medical Group
![]() Sobol Orthopedic Medical Group Medical/Nursing ServicesHealth Services Sobol Orthopedic Medical Group provides chiropractic services. | Corporate Officer/Principal | - |
S&B Surgery Center | Directeur/Membre du Conseil | 01/01/2004 |
Anciens postes connus de Philip A. Sobol
Sociétés | Poste | Fin |
---|---|---|
ENTIA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 03/12/2015 |
University of Southern California
![]() University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 01/01/1993 |
Cordex Pharma, Inc.
![]() Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | - |
Formation de Philip A. Sobol
Rochester Christian University | Undergraduate Degree |
University of Southern California | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ENTIA BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Cordex Pharma, Inc.
![]() Cordex Pharma, Inc. Medical SpecialtiesHealth Technology Cordex Pharma, Inc. is a specialty pharmaceutical company that develops new cardiovascular medicines based upon the emerging pharmacology of adenosine 5'-triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Cordex Pharma was founded on February 9, 1996 and is headquartered in Philadelphia, PA. | Health Technology |
Sobol Orthopedic Medical Group
![]() Sobol Orthopedic Medical Group Medical/Nursing ServicesHealth Services Sobol Orthopedic Medical Group provides chiropractic services. | Health Services |
S&B Surgery Center |